维维股份拟投资1亿元设立全资子公司维维生物科技

Core Viewpoint - The company, Weiweijia (维维股份), announced plans to invest 100 million yuan to establish a wholly-owned subsidiary, Weiweijia Biotechnology, aimed at optimizing resource allocation and enhancing core business strategies [1] Group 1: Investment and Strategic Goals - The investment aligns with the company's long-term development plan and is expected to lead to a transition towards higher value dimensions in its business [1] - The establishment of the subsidiary is intended to continuously consolidate and strengthen the company's core competitiveness [1] - The move is seen as a strategic initiative to create a high-level value creation platform, which is beneficial for the company's development [1]